The stakes are high for life sciences marketing, where balancing marketing innovation with regulatory compliance is essential. Discover our latest insights on how effective marketing governance supports both.
Compounding pharmacies have a role in patient care, but they must adhere to the highest regulatory standards to ensure public trust. Regulatory agencies and media companies should act to ensure that compounded drugs are marketed responsibly and in compliance with FDA guidance or APC best practices.
Governance, Not Overregulation, is the DTC Solution.
The new regulatory environment for pharma commercial marketing
Especially in a time of regulatory uncertainty, strong marketing governance is the most effective way to ensure that pharmaceutical promotions are compliant, so consumers can continue to have access to accurate, science-based health knowledge amid a sea of misinformation.
PREPARING PROMOTIONAL REVIEW FOR OMNICHANNEL MARKETING.
The on-demand DIA webinar with FDA and Hale Advisors
Omnichannel experts Jason Cober from FDA and Zoë Dunn explain omnichannel and modular content in pharma. Learn how to amend your promotional review and OPDP submission processes and get insights on preparing review teams to transition to modular content. Recorded March 12, 2024, at DIA’s Advertising and Promotion Regulatory Affairs Conference.
Is Omnichannel Even Right For Pharma?
The MM+M interview
Zoë Dunn and former MM+M Editor-in-chief Larry Dobrow break down the current state of omnichannel in pharma and share industry insights to apply to your change roadmap.
